Concurrent Chemoradiotherapy Clinical Trial
Official title:
A Randomized Multicenter Phase II/III Study of Optimized Treatment Strategies for Stage II and III Nasopharyngeal Carcinoma
The purpose of this study is to optimize treatment strategies for patients with stage II and III nasopharyngeal carcinoma, reduce the side effects related to treatment and improve the quality of life.
The data came from conventional studies showed that the distant metastases and toxicities associated with concurrent chemoradiotherapy were main problems for patients with clinical stage II and III nasopharyngeal carcinoma. However, inductive chemotherapy can decrease the likelihood of emergence of distant metastasis and reduce treatment related toxicities as previous studies showed. The role of inductive chemotherapy in screening low-risk nasopharyngeal carcinoma for less treatment intensity is under-evaluated in the era of intensity-modulated radiotherapy (IMRT). we hope to find the optimized treatment strategies by reducing the intensity of treatment according to the treatment response of inductive chemotherapy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05621707 -
Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)
|
Phase 2 | |
| Recruiting |
NCT01180166 -
Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT06342167 -
Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
|
Phase 2 | |
| Not yet recruiting |
NCT06288373 -
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03963882 -
NAC Followed by RH for the Treatment of LACC
|
Phase 2 | |
| Recruiting |
NCT05944809 -
The Effect of Prophylactic TPO Combined With BMS-IMRT to Esophageal Cancer Patients
|
Phase 2 | |
| Recruiting |
NCT03579004 -
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
|
Phase 2 | |
| Completed |
NCT02607982 -
CCRT for Esophageal Cancer.
|
Phase 2 | |
| Recruiting |
NCT06378840 -
the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer
|
||
| Recruiting |
NCT06391190 -
Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer
|
Phase 1/Phase 2 |